Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe atopic dermatitis
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderat…
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderat…
TOPIC FOR GENERAL KNOWLEDGE & GENERAL AWARENESS Facts about India India's…
Inviting applications for various post under Integrated Disease Surveillance Proje…
Diabetes is of primarily two types – Diabete mellitus (Type-I and Type II) and Diabet…
Takeda pledges support to HAE patients through its ‘Sunrise patient support program’ …